# China NMPA Drug Inspection - Guangdong Bangmin Pharmaceutical Factory Co., Ltd. - Amoxicillin capsules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/guangdong-bangmin-pharmaceutical-factory-co-ltd/5f40a4f1-3ae4-493b-9584-96ba3ce1c5fb/
Source feed: China

> China NMPA drug inspection for Guangdong Bangmin Pharmaceutical Factory Co., Ltd. published July 28, 2022. Drug: Amoxicillin capsules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Information Bulletin on Drug Quality Sampling Inspection in Qinghai Province (Issue 1, 2022)
- Company Name: Guangdong Bangmin Pharmaceutical Factory Co., Ltd.
- Publication Date: 2022-07-28
- Drug Name: Amoxicillin capsules
- Inspection Finding: qualified

Company: https://www.globalkeysolutions.net/companies/guangdong-bangmin-pharmaceutical-factory-co-ltd/f9ff829e-e04b-457b-81de-631ec08bba9b/